• Therapeutic Cataract & Refractive
  • Lens Technology
  • Glasses
  • Ptosis
  • AMD
  • COVID-19
  • DME
  • Ocular Surface Disease
  • Optic Relief
  • Geographic Atrophy
  • Cornea
  • Conjunctivitis
  • LASIK
  • Myopia
  • Presbyopia
  • Allergy
  • Nutrition
  • Pediatrics
  • Retina
  • Cataract
  • Contact Lenses
  • Lid and Lash
  • Dry Eye
  • Glaucoma
  • Refractive Surgery
  • Comanagement
  • Blepharitis
  • OCT
  • Patient Care
  • Diabetic Eye Disease
  • Technology

Acuvue Oasys for Astigmatism expands parameters

Article

Johnson & Johnson Vision Care, Inc. announced that effective April 15, 2014, Acuvue Oasys for Astigmatism will be available in more parameters.

Jacksonville, FL-Johnson & Johnson Vision Care, Inc. announced that effective April 15, 2014, Acuvue Oasys for Astigmatism will be available in more parameters.

Parameters are being expanded to include -6.00 D to +6.00 D in 0.25 D steps and from -6.50 D to -9.00 D in 0.50 D steps.

With the introduction of these new parameters, the company also announced that effective March 31, 2014, diagnostic lenses for Acuvue Advance for Astigmatism will no longer be available from Johnson & Johnson Vision Care, Inc.   

“In a clinical trial with Acuvue Advance for Astigmatism contact lens wearers, virtually 100% of patients had a prescription match and 100% of patients had first fit success with Acuvue Oasys for Astigmatism,” says W. Lee Ball, OD, FAAO, associate director, professional affairs, Johnson & Johnson Vision Care, Inc.  

Related Videos
Charles Leclercq, CEO of ARxVision, details the new ARx AI headset and its uses
© 2024 MJH Life Sciences

All rights reserved.